Acute Undifferentiated Leukemia: Clinical Trials

1 trial for Acute Undifferentiated Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Acute Undifferentiated Leukemia: new trials by email Literature Review of Acute Undifferentiated Leukemia trials Research Report on Acute Undifferentiated Leukemia

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Asparaginase, Biospecimen Collection, Bone Marrow Biopsy - Acute Lymphoblastic Leukemia, Acute Undifferentiated Leukemia
Phase 3CompletedChildren's Oncology Group2182008-01-152024-07-15

Narrower conditions

Leukemia, Biphenotypic, Acute (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Leukemia (1)  ·  Leukemia, Lymphoid (1)  ·  Lymphatic Diseases (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

Asparaginase (1)  ·  Biopsy (1)  ·  Calcium Dobesilate (1)  ·  Cyclophosphamide (1)  ·  Cytarabine (1)  ·  Daunorubicin (1)  ·  Dexamethasone (1)  ·  Etoposide (1)  ·  Filgrastim (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Hydrocortisone (1)  ·  Leucovorin (1)  ·  Leyk (1)  ·  Medrol Veriderm (1)  ·  Mercaptopurine (1)

Sponsors

Children's Oncology Group (1)

Countries

Australia (1)  ·  Canada (1)  ·  New Zealand (1)  ·  United States (1)

Top investigators

Joanne M Hilden (1)

Results publications

PMID 32414848

NIH funding

U10CA098543 (1), U10CA180886 (1)